author-photo

David Hall

Boehringer Ingelheim

26

Papers

1908

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis

2019 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (94)
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.

2018 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (73)
Efficacy and Safety of Open-Label Maintenance Therapy with Subcutaneous Risankizumab in Patients with Moderateto-Severe Crohn's Disease

2017 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (3)
812a Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (13)
The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations

2015 Statistics in Biopharmaceutical Research
Show All
- Source
- Cite
- Save
Citations (17)
Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial

2015 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (174)
Planning and core analyses for periodic aggregate safety data reviews

2011 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (22)
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.

2011 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (9)
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score

2010 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (16)
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.

2009 PLOS Medicine
Show All
- Source
- Cite
- Save
Citations (90)